Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vascular Access Patency”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Not applicableApproved For MarketingNCT02477891
What this trial is testing

Early Access Treatment With Daratumumab for (Relapsed or Refractory) Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC
Not applicableUnknownNCT04861389
What this trial is testing

Distal Transradial Access for Primary Percutaneous Coronary Intervention in STEMI Patients

Who this might be right for
Acute ST-segment Elevation Myocardial InfarctionRadial Artery OcclusionDistal Radial Artery Approach
Shenzhen People's Hospital 414
Testing effectiveness (Phase 2)Study completedNCT02348528
What this trial is testing

Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Who Participated in CC-5013-MM021 for at Least 1 Year

Who this might be right for
Multiple Myeloma
Celgene 65
Not applicableApproved For MarketingNCT04552691
What this trial is testing

Open-Label Expanded Access Treatment With Pegunigalsidase Alfa for Fabry Disease Patients

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A.
Not applicableStudy completedNCT00946114
What this trial is testing

To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks

Who this might be right for
Pulmonary Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 32
Not applicableStudy completedNCT04452331
What this trial is testing

Assessing Open Access Audio

Who this might be right for
HypertensionDiabetes
VA Office of Research and Development 1,553
Not applicableLooking for participantsNCT05644314
What this trial is testing

Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis

Who this might be right for
Ischemic StrokeVertebral Artery Stenosis
Nanfang Hospital, Southern Medical University 144
Not applicableTemporarily pausedNCT04559334
What this trial is testing

Compassionate-Use of 4% T-EDTA Lock Solution for Central Venous Lines of Pediatric PN Patients

Who this might be right for
Central Line ComplicationCentral Line-associated Bloodstream Infection (CLABSI)
Boston Children's Hospital 15
Not applicableUnknownNCT06034717
What this trial is testing

Primary Patency in Pediatric Patients With Hemodialysis Access

Who this might be right for
The Aim of This Study is to Follow up Short Term "3-6 Months"& Mid Term" 6-12months "Outcomes of Vascular Access" Native and Synthetic "in ESRD Pediatrics
Alaa Gameil Abd El-salam Hussien 60
Not applicableStudy completedNCT04386954
What this trial is testing

Outcomes of Renal Access Arteriovenous Fistulas for Hemodialysis in Patients With Chronic Renal Failure

Who this might be right for
End Stage Renal Disease
Institute of Liver and Biliary Sciences, India 52
Testing effectiveness (Phase 2)Study completedNCT02335099
What this trial is testing

Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis

Who this might be right for
End Stage Renal DiseaseVascular Access Patency
University of Virginia 54
Not applicableStudy completedNCT02111655
What this trial is testing

Improving Arteriovenous Fistula Patency

Who this might be right for
Thrombosis
Hospital Infanta Sofia 212
Large-scale testing (Phase 3)WithdrawnNCT01681524
What this trial is testing

Open Label Study to Access Flurpiridaz F18 in PET MPI Verses SPECT MPI

Who this might be right for
Coronary Artery Disease
Lantheus Medical Imaging
Large-scale testing (Phase 3)Study completedNCT04687137
What this trial is testing

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Takeda 12
Large-scale testing (Phase 3)Ended earlyNCT00379366
What this trial is testing

External Ionizing Radiation to Prevent Restenosis on Haemodialysis Vascular Access

Who this might be right for
Renal Insufficiency, ChronicGraft Occlusion, VascularThrombosis+1 more
University Hospital, Bordeaux 5
Not applicableUnknownNCT05165797
What this trial is testing

Platelet Activation Affecting the Rate of Vascular Access Patency

Who this might be right for
Platelet ActivationHemodialysis Fistula Thrombosis
Korea University Anam Hospital 30
Large-scale testing (Phase 3)Study completedNCT02414841
What this trial is testing

Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)

Who this might be right for
Chronic Kidney Disease
Proteon Therapeutics 696
Large-scale testing (Phase 3)Study completedNCT02565953
What this trial is testing

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon

Who this might be right for
Arteriovenous Fistula Renal Dialysis Devices Obstruction
Fundación Pública Andaluza Progreso y Salud 134
Not applicableStudy completedNCT00890045
What this trial is testing

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Who this might be right for
Renal Failure Chronic Requiring Hemodialysis
Merit Medical Systems, Inc. 72
Testing effectiveness (Phase 2)Study completedNCT00039767
What this trial is testing

Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices

Who this might be right for
Thrombosis
National Institutes of Health Clinical Center (CC) 340
Next Page